Ecolab Q3 2026 Earnings: Organic Sales Accelerate as Acquisition Costs Weigh on EPS
Ecolab reported Q3 2026 net sales of $4.69 billion, up 13% year over year, driven by 7% organic sales growth and strong contributions from Global Water and Life Sciences. Adjusted diluted EPS rose 5% to $2.18, constrained by acquisition amortization and financing costs from CoolIT. Operating performance benefited from effective pricing and productivity gains offsetting commodity inflation. For the full year, Ecolab expects adjusted EPS of $8.10 to $8.20, representing 8% to 9% growth. Key risks include ongoing acquisition cost headwinds, commodity inflation pressures, and geopolitical or customer disruptions.
Ecolab (NYSE: ECL) reported Q3 2026 sales of $4.69 billion, up 13% year over year, while reported diluted EPS fell 5% to $1.95 from $2.05. Organic sales grew 7% as pricing accelerated to 5% and volume rose 2%; adjusted diluted EPS increased 5% to $2.18 despite an approximately 10% headwind from CoolIT-related amortization and financing costs.
Core Financial Results
For the quarter ended September 30, reported operating income rose more slowly than revenue, while reported net income declined. On an adjusted basis, operating income increased 14% as sales growth and productivity gains more than offset higher commodity costs and growth investments.
The gap between reported and adjusted results reflects acquisition amortization, financing expenses, and acquisition and integration charges. Adjusted net income increased 4%, compared with a 6% decline in reported net income.
| Metric | Q3 2026 | Q3 2025 | Year-Over-Year Change |
|---|---|---|---|
| Net sales | $4,694.8 million | $4,165.0 million | +13% |
| Organic sales | $4,452.3 million | $4,174.9 million | +7% |
| Reported operating income | $810.5 million | $760.2 million | +7% |
| Adjusted operating income | $893.4 million | $786.7 million | +14% |
| Reported net income | $551.3 million | $585.0 million | -6% |
| Adjusted net income | $615.4 million | $590.7 million | +4% |
| Reported diluted EPS | $1.95 | $2.05 | -5% |
| Adjusted diluted EPS | $2.18 | $2.07 | +5% |
Business and Segment Performance
Global Water remained Ecolab’s largest growth contributor, benefiting from both acquisitions and faster organic growth. Life Sciences posted the fastest operating income growth, while Institutional & Specialty maintained margin expansion despite weaker restaurant traffic in North America.
| Segment | Fixed-Currency Sales | Fixed-Currency Sales Growth | Organic Sales Growth | Fixed-Currency OI Growth | OI Margin |
|---|---|---|---|---|---|
| Global Water | $2,479.6 million | +20% | +9% | +24% | 18.0% |
| Global Institutional & Specialty | $1,638.3 million | +3% | +3% | +8% | 24.7% |
| Global Pest Elimination | $363.5 million | +9% | +8% | +6% | 20.3% |
| Global Life Sciences | $215.8 million | +17% | +17% | +49% | 23.3% |
Global Water’s fixed-currency growth included an 11-percentage-point contribution from Ovivo Electronics and CoolIT. Within the segment, Global High-Tech organic sales increased 63%, while Food & Beverage grew 8%. Light Water improved, and Heavy Water and Paper returned to growth as pricing, new business wins, and market conditions strengthened.
Institutional & Specialty’s 3% organic growth reflected pricing and new business wins, which offset a mid-single-digit decline in North American restaurant traffic. Pest Elimination grew organically by 8%, although investment in its pest intelligence platform limited operating income growth relative to sales.
Life Sciences benefited from share gains in bioprocessing, personal care, and purification, as well as an easier comparison following plant maintenance in the prior-year period. Separately, Ecolab Digital sales increased 34% to $129 million.
Acquisition Costs Limited EPS Growth Despite Faster Operating Income
Reported operating margin was 17.3%, while organic operating income margin reached 19.6%, an increase of 70 basis points. Reported gross margin was 44.1%; adjusted gross margin declined 70 basis points because of M&A effects, but organic gross margin was stable as higher pricing offset rising commodity costs.
Acquisition-related expenses explain why operating momentum did not fully translate into EPS growth. Net interest expense increased by $70 million due to financing for Ovivo Electronics and CoolIT. Corporate operating expense rose to $162.0 million from $76.5 million, including $79.1 million of acquisition-related amortization and $82.9 million of special charges, primarily for acquisition and integration activities.
The reported tax rate also increased to 20.2% from 17.8%. Together, these items contributed to reported EPS declining even as adjusted operating income grew at a double-digit rate.
2026 Guidance
Ecolab expects full-year adjusted EPS of $8.10 to $8.20, representing growth of 8% to 9%. The outlook includes an approximately six-percentage-point headwind from CoolIT-related amortization and financing costs, with an even larger short-term effect expected in Q4.
| Metric | Latest Guidance | Context |
|---|---|---|
| Full-year 2026 adjusted diluted EPS | $8.10–$8.20 | +8% to +9%; approximately 6-point CoolIT headwind |
| Q4 reported sales growth | +12% to +14% | Includes Ovivo Electronics and CoolIT |
| Q4 organic sales growth | +6% to +7% | Pricing and further volume growth expected |
| Q4 adjusted operating income margin | Approximately 19% | — |
| Q4 organic operating income margin | Approximately 20% | — |
| Q4 adjusted diluted EPS | $2.13–$2.23 | +2% to +7%; approximately 12-point CoolIT headwind |
| Full-year quantifiable special charges | Approximately $0.83 per share | Mainly restructuring, acquisition, and integration costs |
| Q4 quantifiable special charges | Approximately $0.26 per share | Mainly acquisition, integration, and restructuring costs |
Looking further ahead, management expects 2027 organic sales growth at the upper end of its 5% to 7% target and an adjusted operating income margin of 20%. It also expects adjusted EPS growth to accelerate in the second half of 2027 as acquisition-related comparisons ease.
Recent Insider Transactions
The supplied six-month summary shows 46,947 shares purchased across 22 transactions and 36,790 shares sold across five transactions, resulting in net purchases of 10,157 shares. The transactions below are the most recent entries with a clearly identified transaction type and reported value; they should be viewed as disclosures rather than evidence of management’s outlook.
| Date | Insider | Position | Transaction | Price per Share | Reported Value |
|---|---|---|---|---|---|
| Sep. 11, 2026 | Eric Mark Green | Director | Purchase | $276.58–$277.29 | $1,020,798 |
| Aug. 18, 2026 | Christophe Beck | CEO | Sale | $280.14 | $5,003,825 |
| Aug. 11, 2026 | Gregory B. Cook | Officer | Sale | $285.13 | $1,302,300 |
| Jul. 30, 2026 | Scott D. Kirkland | CFO | Derivative security exercise/conversion | $117.73 | $467,624 |
| Jul. 30, 2026 | Scott D. Kirkland | CFO | Sale | $276.96 | $929,755 |
Risks Investors Should Watch
- Acquisition-related earnings pressure: CoolIT amortization and financing costs reduced adjusted EPS growth by approximately 10% in Q3 and are expected to create a roughly 12-percentage-point headwind in Q4.
- Commodity costs and pricing execution: Organic gross margin remained stable because 5% pricing offset rising commodity costs. Further cost inflation could pressure margins if pricing or productivity does not keep pace.
- Geopolitical and customer disruptions: Ecolab cited ongoing Middle East disruptions, changing trade policies, and weaker North American restaurant traffic as operating challenges.
- Near-term investment effects: Pest Elimination expects margins in the high-teens to 20% range over the next few quarters as it invests in connected pest intelligence. Life Sciences also expects its Q4 margin to return toward a high-teens trajectory as investment continues.
Summary
Ecolab’s Q3 2026 results showed faster organic sales and adjusted operating income growth, led by Global High-Tech, Life Sciences, and acquisition-supported expansion in Global Water. Pricing and productivity protected organic margins from commodity inflation, but acquisition amortization, financing, and integration costs limited EPS growth and reduced reported earnings. The main follow-up points are whether volume continues to improve, commodity costs remain covered by pricing, and the acquired businesses begin contributing with a smaller earnings headwind.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles










Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.